Integrins in head and neck squamous cell carcinoma (HNSCC): A review of the current literature

Cell Communication and Adhesion

Volumn 12, Issue 1-2, 2005, Pages 1-8

  Georgolios, A K ^a   Batistatou, A ^a   Charalabopoulos, K A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adhesion molecules; Head and neck carcinoma; Integrins

Indexed keywords

INTEGRIN; INTEGRIN RECEPTOR;

CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; DISEASE MODEL; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; INTEGRINS;

EID: 31344465697     PISSN: 10615385     EISSN: 15435180     Source Type: Journal    
DOI: 10.1080/15419060500383093     Document Type: Review

References (64)

1. Hynes, R. (1992). Integrins: Versatility, modulation and signaling in cell adhesion. Cell, 69, pp. 11-25. [PUBMED] [INFOTRIEVE] [CSA]
2. Lee, J and Rieu, P and Arnaout, M and Liddington, R. (1995). Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/ CD18). Cell, 80(4), pp. 631-638. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
3. Berman, A and Kozlova, N and Morozevich, G. (2003). Integrins: Structure and signalling. Biochemistry, 68(12), pp. 1284-1299. [PUBMED] [INFOTRIEVE] [CSA]
4. Mould, P. and Askari, J and Humphries, M. (2000). Molecular basis of ligand recognition by integrin α 5β 1. Biol Chem, 275, pp. 20324-20336. [CSA] [CROSSREF]
5. Li, R and Babu, C and Valentine, K and Lear, J and Wand, A and Bennett, J and DeGrado, W. (2002). Characterisation of the monomeric form of the transmembrane and cytoplasmic domains of the integrin beta 3 subunit by NMR spectroscopy. Biochemistry, 41(52), pp. 156. [CSA] [CROSSREF]
6. Tamura, R and Rozzo, C and Starr, L and Chambers, J and Reichardt, L and Cooper, H and Quaranta, V. (1990). Epithelial integrin alpha 6 beta 4: Complete primary structure of alpha 6 and variant forms of beta 4. J Cell Biol, 111, pp. 1593-1604. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
7. Kuhn, K and Eble, J. (1994). The structural bases of integrin-ligand interactions. Trends Cell Biol, 4(7), pp. 256-261. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
8. Charalabopoulos, K and Pignatelli, M. (2001). Adhesion molecules and cancer. Arch Hell Med, 18(1), pp. 16-19. [CSA]
9. Wehrle-Haller, B and Imhof, B. (2003). Integrin dependent pathologies. J Pathol, 200, pp. 481-487. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
10. Charalabopoulos, K and Binolis, J and Karkabounas, S. (2002). Adhesion molecules in carcinogenesis. Exp Oncol, 24, pp. 249-257. [CSA]
11. Gogali, A and Charalabopoulos, K and Constantopoulos, S. (2004). Integrins receptors in primary lung cancer. Exp Oncol, 26(2), pp. 106-110. [PUBMED] [INFOTRIEVE] [CSA]
12. Maree, A and Fitzgerald, D. (2003). Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: Where are we now? Semin Vasc Med, 3, pp. 385-390. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
13. Li, E and Brown, S and Stupack, D and Puente, X and Cheresh, D and Nemerow, G. (2001). Integrin avβ 1 is an adenovirus coreceptor. J Virol, 75, pp. 5405-5409. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
14. Calvette, J. (2004). Structures of integrin domains and concerted conformational changes in the bidirectional signalling mechanism of aIIbβ3. Exp Biol Med, 229, pp. 723-744. [CSA]
15. Humphries, M. (2004). Monoclonal antibodies as probes of integrin priming and activation. Biochem Soc Trans, 32, pp. 407-411. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
16. Sturgis, E and Wei, Q and Spitz, M. (2004). Descriptive epidemiology and risk factors for head and neck cancer. Sem Oncol, 31, pp. 726-733. [CSA] [CROSSREF]
17. Sanderson, R and Montague. (2004). Surgical management of head and neck malignancy. Surg J R Coll Edinb Irel, 2, pp. 7-14. [CSA]
18. Cortesina, G and Bussi, M and Carlevato, M and Ferro, S and Panizzut, B and Cavalot, A and Gervasio, C and Marchisio, P. (1996). Significance of adhesion molecules as biological prognostic factors in locally advanced SCCHN. Acta Otol, 116, pp. 350-352. [CSA]
19. Quon, H and Liu, F and Cummings, B. (2001). Potential molecular prognostic markers in HNSCC. Head and Neck, pp. 147-159. [CSA] [CROSSREF]
20. Rhee, D and Wenig, B and Smith, R. (2002). The significance of immunohistochemically demonstrated nodal micrometastases in patient with SCCHN. Laryngoscope, 112, pp. 1970-1974. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
21. Moon, C and Oh, Y and Roth, J. (2003). Current Status of Gene Therapy for Lung Cancer and Head and Neck Cancer. Clinical Cancer Research, 9, pp. 5055-5067. [PUBMED] [INFOTRIEVE] [CSA]
22. Juliano, R and Varner, J. (1993). Adhesion molecules in cancer: The role of integrins. Curr Opin Cell Biol, 5, pp. 812-818. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
23. Mizejewski, G. (1999). Role of integrins in cancer: Survey of expression patterns. Proceedings of the Soc Exp Biol Med, 222, pp. 124-138. [CSA] [CROSSREF]
24. Felding-Habermann, B. (2003). Integrin adhesion receptor in tumour metastasis. Clin Exp Metast, 20, pp. 203-213. [CSA] [CROSSREF]
25. Maurizi, M and Scambia, G and Benedetti Panici, P. (1992). EGF receptor expression in primary laryngeal cancer: Correlation with clinico-pathological features and prognostic significance. Int J Cancer, 52, pp. 862-866. [PUBMED] [INFOTRIEVE] [CSA]
26. Grandis, J and Melhem, M and Gooding, W. (1998). Levels of TGF-alpha and EGFR protein in HNSCC and patient survival. J Natl Cancer Invest, 90, pp. 824-832. [CSA] [CROSSREF]
27. Pignataro, L and Pruneri, G and Carboni, N and Pignataro, L and Capaccio, P and Cesana, B and Neri, A and Buffa, R. (1998). Clinical relevance of cyclin-D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol, 16, pp. 3069-3077. [PUBMED] [INFOTRIEVE] [CSA]
28. Pavelic, Z and Gluckman, J. (1997). The role of p53 tumour suppressor gene in human head and neck tumorigenesis. Acta Otolaryngol, 527, pp. 21-24. [CSA]
29. Marchisio, P and Bondanza, S and Cremona, O and Cancedda, R and De Luca, M. (1991). Polarised expression of integrins receptors (α 6β 4, α 2β 1, α 3β 1, α ν β 5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J Cell Biol, 112, pp. 761-773. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
30. Carter, W and Waynes, E and Bouchard, T and Kour, P. (1990). The role of integrins α 2β 1 and α 3β 1 in cell-cell and cell substrate adhesion of human epidermal cells. J Cell Biol, 110, pp. 1378-1340. [CSA] [CROSSREF]
31. Haapasalmi, K and Zhang, K and Tonnesen, M and Olerud, J and Sheppard, D and Salo, T and Kramer, R and Clark, R and Uitto, V and Larjava, H. (1996). Keratinocytes in human wounds express avβ 6 integrin. J Invest Dermatol, 106, pp. 1-7. [CSA] [CROSSREF]
32. Clark, R and Ashcroft, G and Spencer, M-J and Larjaua, H and Ferguson, M. (1996). Re-epithelialisation of normal human excisional wounds is associated with a switch from α ν β 5 to α ν β 6 integrins. Br J Dermatol, 135, pp. 46-51. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
33. Jones, J and Sugiyama, M and Watt, F and Speight, P. (1993). Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. J Pathol, 169, pp. 235-243. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
34. Thomas, G and Jones, J and Speight, P. (1997). Integrins and oral cancer. Oral Oncology, 33, pp. 381-388. [PUBMED] [INFOTRIEVE] [CSA]
35. Walsh, L and Coyne, R and Xu, L and Savage, N. (1996). The role of adhesion molecules in oral cancer. Austr Dent J, 41, pp. 80-82. [CSA]
36. Chainani-Wu, N and Lagenaur, L and Penaranda, M and Palefsky, J. (2000). Integrin expression in oral hairy leukoplakia and normal tongue epithelium. Oral Dis, 6, pp. 234-240. [PUBMED] [INFOTRIEVE] [CSA]
37. Ricci, E and Cavalot, A and Sanvito, F and Bussi, M and Staffieri, A and Cortesina, G and Marchisio, P. (2002). Differential expression and topography of adhesion molecules in laryngeal and oropharyngeal carcinomas. Acta Otolaryngol, 122, pp. 234-240. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
38. Maragou, P and Bazopoulou-Kyrkanidou, E and Panotopoulou, E and Kakarantza-Angelopoulou, E and Sklavounou-Andrikopoulou, A and Kotaridis, S. (1999). Alteration of integrin expression in oral squamous cell carcinomas. Oral Dis, 5, pp. 20-26. [PUBMED] [INFOTRIEVE] [CSA]
39. Gasparoni, A and Fonzi, L and Scnheider, G and Wertz, P and Johnson, G and Squier, C. (1996). Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch Biol, 49(8), pp. 653-664. [CSA] [CROSSREF]
40. Gianneli, G and Milillo, L and Marinosci, F and Lo Muzio, L and Serpico, R and Antonaci, S. (2001). Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa. J Biol Homeost Agents, 15(4), pp. 375-380. [CSA]
41. Carlevato, M and Trusolino, L and Serini, G and Valente, G and Orlandi, F and Angeli, A and Cortesina, G and Marchisio, P. (1996). Differential integrin expression in thyroid and laryngeal carcinomas. Anticancer Res, 16(4C), pp. 2379-2384. [PUBMED] [INFOTRIEVE] [CSA]
42. Lalonde, E and Beyer, G and Friedlander, P and Kolls, J. (2002). Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: An in vivo and in vitro study. Head and Neck, 24(12), pp. 1038-1046. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
43. Jones, J and Watt, F and Speight, P. (1997). Changes in the expression of α ν integrins in oral suamous cell carcinomas. J Oral Pathol Med, 26, pp. 63-68. [PUBMED] [INFOTRIEVE] [CSA]
44. Regezi, J and Ramos, D and Pytela, R and Dekker, N and Jordan, R. (2002). Tenascin and β 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol, 38, pp. 332-336. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
45. Thomas, G and Lewis, P and Whawell, S and Russel, A and Sheppard, D and Hart, I and Speight, P and Marshall, J. (2001). Expression of the α ν β 6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol, 117, pp. 67-80. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
46. Ramos, D and But, M and Regezi, J and Schmidt, B and Atakilit, A and Dang, D and Ellis, D and Jordan, R and Li, X. (2002). Expression of integrin β 6 enhances invasive behaviour in oral squamous cell carcinoma. Matrix Biol, 21, pp. 297-307. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
47. Xue, H and Atakilit, A and Zhu, W and Li, X and Ramos, D and Pytela, R. (2001). Role of the α ν β 6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun, 288, pp. 610-618. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
48. Wang, A and Patrone, L and McDonald, J and (1995). Expression of the integrin subunit α 9 in the murine embryo. Devel Dynam, 204, pp. 421-431. [CSA]
49. Hakkinen, L and Kainulainen, T and Salo, T and Grenman, R and Larjava, H. (1999). Expression of integrin α 9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis, 5, pp. 210-217. [PUBMED] [INFOTRIEVE] [CSA]
50. Stepp, M and Zhu, L. (1997). Upregulation of alpha 9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem, 45, pp. 189-201. [PUBMED] [INFOTRIEVE] [CSA]
51. Liu, S and Slepak, M and Ginsberg, M. (2001). Binding of Paxillin to the alpha 9 Integrin Cytoplasmic Domain Inhibits Cell Spreading. J Biol Chem, 276, pp. 37086-37092. [PUBMED] [INFOTRIEVE] [CSA]
52. Downer, C and Watt, F and Speight, P. (1993). Loss of alpha 6 and beta 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol, 171(3), pp. 183-190. [PUBMED] [INFOTRIEVE] [CSA]
53. Liebert, M and Washington, R and Wedemeyer, G and Carey, T and Grossman, H. (1994). Loss of co-localization of alpha 6 beta4 integrin and collagen VII in bladder cancer. Am J Pathol, 144, pp. 787-795. [PUBMED] [INFOTRIEVE] [CSA]
54. Bagutti, C and Speight, P and Watt, F. (1998). Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol, 186, pp. 8-16. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
55. Dyce, O and Ziober, A and Weber, R and Miyazaki, K and Khariwala, S and Feldman, M and Ziober, B. (2002). Integrins in head and neck squamous cell carcinoma invasion. Laryngoscope, 112(11), pp. 2025-2032. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
56. Kosmehl, H and Berndt, A and Katenkamp, D and Hyckel, P and Stiller, K-J and Gabler, U and Langbein, L and Reh, T. (1995). Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study. J Oral Pathol Med, 24, pp. 343-348. [PUBMED] [INFOTRIEVE] [CSA]
57. Garzino-Demo, P and Carrozzo, M and Trusolino, L and Savoia, P and Gandolfo, S and Marchisio, P. (1998). Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol, 34(3), pp. 204-210. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
58. Brooks, P and Montgomery, A and Rosenfeld, M and (1994). Integrin alphav beta3 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell, 79(7), pp. 1157-1164. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
59. Landowski, T and Olashaw, N and Agrawal, D and Dalton, W. (2003). Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells. Oncogene, 22(16), pp. 2417-2421. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
60. Damiano, J and Dalton, W. (2000). Integrin-mediated drug resistance in multiple myeloma. Leuk Lymphoma, 38(1-2), pp. 71-81. [PUBMED] [INFOTRIEVE] [CSA]
61. Ambrioc-Ristov, A and Gabrilovac, J and Cimbora-Zovko, T and Osmak, M. (2004). Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin α ν β 3 and coxxackie adenovirus receptor. Int J Cancer, 110, pp. 660-667. [CSA]
62. Vitolo, D and Ciocci, L and Ferrauti, P and Cicerone, E and Gallo, A and De Vincentiis, M and Baroni, C. (2000). α 5 integrin distribution and TGFβ 1 gene expression in supraglottic carcinoma: Their role in neoplastic local invasion and metastasis. Head Neck, 22, pp. 48-56. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
63. Adachi, M and Taki, T and Ogawa, E and (1997). Expression of integrin alpha3 and alpha5 are associated with prognosis of non-small cell lung cancer. Proceedings of the 88th Annual Meeting of the American Association for Cancer Research, 38, pp. 329. [CSA]
64. Kasono, K and Blackwell, J and Douglas, J and Dmitriev, I and Strong, T and Reynolds, P and Kropf, D and Carvoll, W and Peters, G and Bucy, R and Curiel, D and Krusnykh, V. (1999). Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res, 5, pp. 2571-2579. [PUBMED] [INFOTRIEVE] [CSA]